Precancerous Condition: Clinical Trials

27 trials for Precancerous Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 5 unknown, 2 terminated. 27 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 127Completed 20, Unknown 5, Terminated 2
Phase 24Completed 2, Unknown 2

Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
acetylsalicylic acid, gene expression analysis, protein expression analysis - Precancerous Condition
Phase 1CompletedInstitute of Head and Neck Studies and Education, United Kingdom402010-02-012013-08-12
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, DNA analysis, polymerase chain reaction - Cervical Cancer, Nonneoplastic Condition
Phase 1CompletedAIDS Malignancy Consortium1502009-08-012024-03-19
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
questionnaire administration, comparison of screening methods, diagnostic endoscopic procedure - Esophageal Cancer, Precancerous Condition
Phase 1 / Phase 2UnknownUS Department of Veterans Affairs502009-05-012014-01-10
Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
assessment of therapy complications, diagnostic endoscopic surgery, quality-of-life assessment - Head and Neck Cancer, Perioperative/Postoperative Complications
Phase 1CompletedBarbara Ann Karmanos Cancer Institute62009-05-012014-05-09
Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors
aminolevulinic acid hydrochloride - Head and Neck Cancer, Precancerous Condition
Phase 1CompletedAbramson Cancer Center at Penn Medicine352009-01-012019-04-23
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
TA-HPV, pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine, imiquimod - Cervical Cancer, Precancerous Condition
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins752008-11-012023-08-31
Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
carboplatin, cidofovir, protein expression analysis - Cervical Cancer, Precancerous Condition
Phase 1UnknownGustave Roussy, Cancer Campus, Grand Paris242008-04-012010-01-28
Erlotinib in Treating Patients With Barrett Esophagus
erlotinib hydrochloride, laboratory biomarker analysis, biopsy - Esophageal Cancer, Precancerous Condition
Phase 1UnknownKansas City Veteran Affairs Medical Center252007-07-012013-09-17
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization - Lung Cancer, Precancerous Condition
Phase 1CompletedBritish Columbia Cancer Agency302007-01-012012-03-09
Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples
microarray analysis, flow cytometry, biopsy - Cervical Cancer, Precancerous Condition
Phase 1TerminatedBritish Columbia Cancer Agency502006-09-012017-02-01
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
therapeutic allogeneic lymphocytes, busulfan, cyclosporine - Chronic Myeloproliferative Disorders, Leukemia
Phase 1 / Phase 2CompletedOHSU Knight Cancer Institute1472005-06-012017-09-27
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
Zoledronate, Placebo (Saline) - Cervical Cancer, Precancerous Condition
Phase 1TerminatedUniversity of California, San Francisco122005-04-012017-11-24
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
silicon phthalocyanine 4 - Lymphoma, Non-melanomatous Skin Cancer
Phase 1CompletedCase Comprehensive Cancer Center432004-09-012019-01-22
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine - Cervical Cancer, Precancerous Condition
Phase 1 / Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins162003-11-012018-07-20
Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
infrared photocoagulation therapy, Infrared Coagulator - Anal Cancer, Precancerous Condition
Phase 1CompletedAIDS Malignancy Consortium182003-09-012014-09-17
Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
inositol - Lung Cancer, Precancerous Condition
Phase 1CompletedBritish Columbia Cancer Agency2003-05-012010-02-02
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
pirfenidone - Neurofibromatosis Type 1, Precancerous Condition
Phase 1CompletedNational Cancer Institute (NCI)2002-12-012015-04-30
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
celecoxib, placebo - Colorectal Cancer, Precancerous Condition
Phase 1CompletedM.D. Anderson Cancer Center222002-11-212018-11-07
Pyroxamide in Treating Patients With Advanced Cancer
pyroxamide - Chronic Myeloproliferative Disorders, Leukemia
Phase 1CompletedMemorial Sloan Kettering Cancer Center2002-04-012013-06-05
Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
Cetuximab - Gastric Cancer, Precancerous Condition
Phase 1CompletedVanderbilt University92001-04-012017-01-10

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Precancerous Conditions (27)  ·  Lymphoma (9)  ·  Burkitt Lymphoma (8)  ·  Leukemia (8)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (8)  ·  Lymphoma, B-Cell, Marginal Zone (8)  ·  Lymphoma, Follicular (8)  ·  Lymphoma, Large B-Cell, Diffuse (8)  ·  Lymphoma, Large-Cell, Immunoblastic (8)  ·  Lymphoma, Mantle-Cell (8)  ·  Lymphoma, Non-Hodgkin (8)  ·  Monoclonal Gammopathy of Undetermined Significance (8)  ·  Multiple Myeloma (8)  ·  Neoplasms, Plasma Cell (8)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (8)

Broader conditions

Neoplasms (27)  ·  Neoplasms by Site (23)  ·  Neoplasms by Histologic Type (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Immune System Diseases (11)  ·  Pathologic Processes (11)  ·  DNA Virus Infections (10)  ·  Disease Attributes (10)  ·  Hemic and Lymphatic Diseases (10)  ·  Immunoproliferative Disorders (10)  ·  Infections (10)  ·  Lymphoproliferative Disorders (10)  ·  Tumor Virus Infections (10)  ·  Virus Diseases (10)  ·  Hematologic Diseases (9)

Interventions

Biopsy (3)  ·  Carboplatin (2)  ·  Microarray Analysis (2)  ·  Amifostine (1)  ·  Aminolevulinic Acid (1)  ·  Aspirin (1)  ·  Bortezomib (1)  ·  Brachytherapy (1)  ·  Bronchoalveolar Lavage (1)  ·  Bronchoscopy (1)  ·  Budesonide (1)  ·  Busulfan (1)  ·  Celecoxib (1)  ·  Cetuximab (1)  ·  Cidofovir (1)

Sponsors

British Columbia Cancer Agency (3)  ·  AIDS Malignancy Consortium (2)  ·  National Cancer Institute (NCI) (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Boston Medical Center (1)  ·  California Cancer Consortium (1)  ·  Case Comprehensive Cancer Center (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Institute of Head and Neck Studies and Education, United Kingdom (1)  ·  Kansas City Veteran Affairs Medical Center (1)  ·  LifeTime Pharmaceuticals (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)

Countries

United States (21)  ·  Canada (3)  ·  France (2)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Cornelia L. Trimble, MD (2)  ·  Stephen Lam, MD (2)  ·  Alex A. Adjei, MD, PhD (1)  ·  Brigitte C. Widemann, MD (1)  ·  Douglas V. Faller, MD, PhD (1)  ·  Elizabeth Stier, MD (1)  ·  Elma Baron, MD (1)  ·  Eric Deutsch, MD (1)  ·  George Thomas Budd, MD (1)  ·  Hisham Mehanna, MD (1)  ·  Ho-Sheng Lin, MD (1)  ·  Howard S. Hochster, MD (1)  ·  Jason A. Dominitz, MD (1)  ·  Jeffrey S. Weber, MD, PhD (1)  ·  Joaquina C. Baranda, MD (1)

Results publications

PMID 17119113, PMID 19118066, PMID 20234350, PMID 24386300, PMID 24477000, PMID 26420854, PMID 33468698, PMID 9628848

NIH funding

P30CA006973 (1), P30CA015083 (1), P30CA016058 (1), P30CA016087 (1), P30CA022453 (1), P30CA043703 (1), P30CA068485 (1), P50CA098252 (1), R01CA103830 (1), R21CA105696 (1), R21CA123876 (1), U01CA069912 (1), U01CA121947 (1)